CEL-SCI Corp - Company Profile
Powered by 
All the sales intelligence you need on CEL-SCI Corp in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how CEL-SCI Corp fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with CEL-SCI Corp.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
CEL-SCI Corp (CEL-SCI) develops products for the treatment of cancer and other diseases. Focused research and development activities, lead product: Multikine, and innovative LEAP technology are its key strengths, even though the history of losses remains a major area of concern. The orphan drug designation, the positive outlook of the global pharmaceutical market, and strategic plans could provide ample growth opportunities for the company. However, non-compliance with government regulations, competitive pressure, and rapid technological changes could harm the company's business.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer